<DOC>
	<DOCNO>NCT02917304</DOCNO>
	<brief_summary>The purpose study evaluate immunological efficacy safety GC3110A among healthy adult 65 year age .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety GC3110A Healthy Subjects Aged 65 Years Older</brief_title>
	<detailed_description>Adults 65 year age administer GC3110A ( Quadrivalent influenza vaccine ) .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy adult age 65 year old Informed consent form sign date Able comply requirement study Known systemic hypersensitivity egg , chicken protein , vaccine component Personal history GuillainBarre syndrome ( GBS ) Subjects severe chronic disease consider investigator ineligible study Subjects receive vaccination within 28 day enrollment schedule another vaccination study Immunocompromised subject immunodeficiency disease subject receive immunosuppressive immunomodulating therapy</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Quadrivalent Influenza Vaccines</keyword>
</DOC>